Elisabeth Hardy

668 total citations
10 papers, 470 citations indexed

About

Elisabeth Hardy is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, Elisabeth Hardy has authored 10 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Elisabeth Hardy's work include Platelet Disorders and Treatments (3 papers), Urinary and Genital Oncology Studies (2 papers) and Urological Disorders and Treatments (2 papers). Elisabeth Hardy is often cited by papers focused on Platelet Disorders and Treatments (3 papers), Urinary and Genital Oncology Studies (2 papers) and Urological Disorders and Treatments (2 papers). Elisabeth Hardy collaborates with scholars based in France, Australia and Denmark. Elisabeth Hardy's co-authors include Martín C. Mihm, G. W. Milton, J. Cooper Booth, Arnold Levene, Martin Lewis, Julian Little, Vincent J. McGovern, Alistair J. Cochran, Wallace H. Clark and Christiane Bailly and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Elisabeth Hardy

9 papers receiving 436 citations

Peers

Elisabeth Hardy

ONCOL

MB

HEMAT

DERMA

EPIDE

Scott R. Dalton United States

Karen S. McGinnis United States

Francisco Cuéllar Spain

Joy H. Kunishige United States

Susanna Rossari Italy

Florian Schenck Germany

Erick Jacobson‐Dunlop United States

Kurtis B. Reed United States

Wilfried H.B.M. Levering Netherlands

Sarah J. Kurley United States

Scott R. Dalton United States

Elisabeth Hardy

363 ×1.2

ONCOL

203 ×1.2

MB

18 ×0.2

HEMAT

149 ×1.9

DERMA

117 ×2.1

EPIDE

Citations per year, relative to Elisabeth Hardy Elisabeth Hardy (= 1×) peers Scott R. Dalton

Countries citing papers authored by Elisabeth Hardy

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Hardy more than expected).

Fields of papers citing papers by Elisabeth Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Hardy. The network helps show where Elisabeth Hardy may publish in the future.

Co-authorship network of co-authors of Elisabeth Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Hardy. A scholar is included among the top collaborators of Elisabeth Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Hardy. Elisabeth Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Guéguen, Paul, Karen Rouault, Jian‐Min Chen, et al.. (2013). A Missense Mutation in the Alpha-Actinin 1 Gene (ACTN1) Is the Cause of Autosomal Dominant Macrothrombocytopenia in a Large French Family. PLoS ONE. 8(9). e74728–e74728. 34 indexed citations

2.

Ianotto, Jean‐Christophe, Adrian Tempescul, Pascal Delépine, et al.. (2011). Delayed G‐CSF stimulation after PBSCT does not seem to modify the biological parameters of bone marrow recovery. American Journal of Hematology. 86(4). 351–352. 2 indexed citations

3.

Tempescul, Adrian, et al.. (2009). Peripheral blood stem cell collection in elderly patients. Annals of Hematology. 89(3). 317–321. 19 indexed citations

4.

Ianotto, Jean‐Christophe, Elisabeth Hardy, Valérie Ugo, et al.. (2007). Inhibitory effect of the substance P and its derivative on erythropoietin-independent growth of erythroid progenitors in polycythemia vera. Leukemia Research. 32(5). 743–754. 1 indexed citations

5.

Guriec, Nathalie, et al.. (2005). Cytokine-regulated expression and inhibitory function of FcγRIIB1 and -B2 receptors in human dendritic cells. Journal of Leukocyte Biology. 79(1). 59–70. 9 indexed citations

6.

Sensebé, Luc, Bruno Giraudeau, Laurent Bardiaux, et al.. (2004). The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood. 105(2). 862–864. 61 indexed citations

7.

Minchiotti, Lorenzo, et al.. (1999). Structural characterization, stability and fatty acid-binding properties of two French genetic variants of human serum albumin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1431(1). 223–231. 14 indexed citations

8.

Fournier, Georges, et al.. (1996). Nephrogenic Adenoma of the Bladder in Renal Transplant Recipients. The Journal of Urology. 41–44. 1 indexed citations

9.

Fournier, Georges, et al.. (1996). Nephrogenic Adenoma of the Bladder in Renal Transplant Recipients: A Report of 9 Cases with Assessment of Deoxyribonucleic Acid Ploidy and Long-Term Followup. The Journal of Urology. 156(1). 41–44. 21 indexed citations

10.

McGovern, Vincent J., Martín C. Mihm, Christiane Bailly, et al.. (1973). The classification of malignant melanoma and its histologic reporting. Cancer. 32(6). 1446–1457. 308 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact